Price $50.77 |
Market Cap
21.5M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
2.35
|
P/S
-
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-37.6K
|
FCF
-
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-183.10%
|
ROI
-
|
|
ROA
-78.40%
|
EPS Growth
-31.00%
|
Current Ratio
4.8
|
Debt/Equity
48.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Marizyme Inc (MRZM) | $0.03 | - | - | 8.6M | Strong Buy |
| Generation Bio Co (GBIO) | $2.32 | - | - | 65.9M | Strong Buy |
| InMed Pharmaceuticals Inc (INM) | $0.27 | - | - | 1.6M | Strong Buy |
| Pressure Biosciences Inc (PBIO) | $0.13 | - | - | 8.4M | Strong Buy |
| Rockwell Medical Inc (RMTI) | $3.04 | - | - | 55M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
